
CJC-1295 + GHRP-210 mg Blend
Explore the format, calculations, and schedules reported for this compound.
Back to peptides
CJC-1295 + GHRP-2, explained simply
A blend pairing a GHRH analogue with a ghrelin-mimicking peptide, two signals that can affect growth hormone release.
Research area
GH/IGF-1 axis and body composition
How it works
CJC-1295 acts through GHRH receptors, while GHRP-2 activates the growth hormone secretagogue receptor.
Why it matters
The pairing draws interest because two different pathways regulate GH release.
What has been observed
Mechanistic and component studies document hormonal responses; they do not by themselves quantify the effect of this particular blend.
Effects and points to consider
GHRP-2 may affect appetite and other hormones. Read the amount of each component separately in the profile.
Reported data
Doses and cycles are presented for information and education only; they are not prescriptions or medical advice.
Reported vial strength and reconstitution
| Total vial mass | 10 mg |
|---|---|
| Final volume | 3 mL |
| Concentration | 3.33 mg/mL |
| Frequency | research-design-dependent in chart; once daily in overview; twice daily in alternative table |
| Cycle | 12 in tables; overview says 8-12 optional 16 |
Standard / Gradual Approach (3 mL = ~3.33 mg/mL)
| Week | Daily Dose (mcg) | Units (per injection) (mL) |
|---|---|---|
| Weeks 1–2 | 150 mcg (0.15 mg) | 4.5 units (0.045 mL) |
| Weeks 3–12 | 300 mcg (0.30 mg) | 9 units (0.09 mL) |
Advanced / Twice-Daily Approach (3 mL = ~3.33 mg/mL)
| Week | Dose per Injection (mcg) | Units (per injection) (mL) | Total Daily (mcg) |
|---|---|---|---|
| Weeks 1–2 | 100 mcg (0.10 mg) | 3 units (0.03 mL) | 200 mcg |
| Weeks 3–12 | 150 mcg (0.15 mg) | 4.5 units (0.045 mL) | 300 mcg |
Supplies needed


Sterile alcohol swabs
Scientific references
Links reported by the source and selected by type. Their presence does not validate this page’s dosage data.